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C5b-8 and C5b-9 modulate the collagen release of human glomerular
epithelial cells. Aside from their lytic function the late complement
components C5b-9 stimulate release of prostanoids, interleukin 1 and
oxygen radicals from a number of cells. Since C5b-9 has also been
connected to the development of sclerosis in animal models of glomer-
ulonephritis, we addressed the question whether C5b-9 would affect the
collagen synthesis. We used human glomerular epithelial cells (GEC)
obtained as primary outgrowth cultures. The cells were cultivated in the
presence of '4C-proline. Collagen synthesis was quantitated by count-
ing the radioactivity associated with collagenase digestible material.
Furthermore, collagen was analyzed by SDS-PAGE. GEC in culture
produce spontaneously some collagen type IV. Addition of sublytic
doses of highly purified C5b-9 increased the collagen synthesis consid-
erably within 12 to 24 hours. In the absence of C9, CSb-8 stimulated
collagen synthesis to a similar extent, whereas in the absence of C7 or
C8, the collagen synthesis was not enhanced. Furthermore, fluid-
phase-formed C5b-9 complexes did not stimulate the collagen synthe-
sis, indicating that assembly of the complex on the target membrane
was required. Since C5b-9 deposits are found in sclerotic areas, our
data support the hypothesis that C5b-9, by stimulating collagen synthe-
sis as well as release, might contribute to the development of chronic
nephritis.
The role of complement in the initiation of glomerulonephritis
is well established: attraction of neutrophils and release of their
enzymes are the major functions of the complement split
products [1, 2]. In the last few years, the role of the terminal
complement components C5b-9 in the development of chronic
glomerulonephritis has gained increasing interest [3—5]. A role
of CSb-9 in the development of proteinuria or sclerosis has been
demonstrated in different animal models [6—8].
The channel-forming terminal complement components are
known for their lytic function [reviewed in 9]: one channel per
erythrocyte is sufficient for lysis. More recently, however, it
was recognized that nucleated cells are quite resistant to the
lytic action of complement; more than one complement channel
is required for killing [10, 11]. Low, sublethal C5b-9 doses,
however, also affect the cell metabolism: release of arachidonic
acid and its metabolites [12—15] was seen as well as release of
oxygen radicals and of interleukin 1 [16]. C5b-9 is also an
efficient stimulator of glomerular cells. Cultured mesangial cells
are triggered by C5b-9 to release prostanoids [17], interleukin 1
[171 and oxygen radicals [18]. Glomerular epithelial cells of the
rat also released prostaglandin E and thromboxane after treat-
ment with sublytic dosis of C5b-9 [19].
In the present study, we addressed the question of whether
C5b-9 would also affect collagen synthesis. We studied synthe-
sis of collagen type IV in cultured glomerular epithelial cells
obtained from rat or human kidneys. In glomerular epithelial
cells derived from two different species, C5b-9 enhanced the
production of collagen.
Methods
Human glomerular epithelial cultures (GEC): GEC were
cultivated from outgrowth cultures of human glomeruli. Gb-
meruli were isolated from kidneys obtained from the Surgical
Hospital (University of Heidelberg), mostly from patients un-
dergoing tumor nephrectomy. The cortex from morphological
healthy tissue was minced and the glomeruli were isolated by
sieving as described by Krakower and Greenspon [20]. The
glomeruli were washed repeatedly in Hanks' balanced salt
solution (HBSS) and were sedimented to remove free cells and
cell debris. After repeated washing and sedimentation cycles,
aside from glomeruli no other particles could be detected. The
glomeruli were suspended (300/mi) in Dulbecco's modified
Eagle's medium (DMEM), supplemented with: 10% heat inac-
tivated fetal calf serum, vitamin mix (x 100)1%, insulin 5 tg/ml
and antibiotic/anti-mycotic 1% (all obtained from Gibco, Egg-
enstein, FRG). The glomeruli were seeded in tissue culture
plates (Primaria, Falcon; Becton and Dickinson, Heidelberg,
FRG). The glomeruli were incubated at 37°C in a moist atmo-
sphere containing 5% Co2 in air. After approximately three
days, most of the glomeruli were adherent. Non-adherent
glomeruli were removed by rinsing with medium. After another
two days, when cells began to sprout around the gbomeruli, the
glomeruli were removed by washing vigorously in medium. The
cells were cultured further until they reached confluence, which
occurred between day 10 and 15.
Subcultures of GEC
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Confluent cell layers were removed with trypsin-EDTA 10 x
diluted 1:5 in PBS (Biochrom, W. Berlin, FRG). The cells were
suspended in undiluted FCS, washed repeatedly and seeded
into tissue culture plates (1 x l0) in the medium described
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Fig. 1. Human glomerularepithelial ce/Is in culture. A. Phase-contrast photograph of a culture at near confluence (magnification x 200). B.
Cytoskeleton staining with antibodies to vimentin and a fluorescence-labeled anti-Ig. C. The insulin receptor, stained by an antibody to insulin
receptor and fluorescence-labeled anti-IgG. D. Staining of the extracellular matrix by antibodies to collagen type IV.
above. The subcultured cells reached confluence after three to
five days. GEC were repeatedly subcultured (up to 4 times)
without changing morphology (judged by phase contrast mi-
croscopy). For the collagen assays, only cells of the first
subculture were used.
Rat podocyte cultures
Rat podocytes were cultivated and characterized as de-
scribed previously [19].
Characterization of the cultured cells
For human GEC, specific markers have not been defined.
Therefore, characterization had to be done by morphological
criteria and exclusion of other glomerular cells [19, 21]. In near
confluent cultures, the cells appeared homogenous (Fig. 1A),
stellate cells (mesangial cells) were not present. Staining the
cytoskeleton after fixation with methanol (100% for 5 mm at
—20°C) and aceton (100% for 20 mm at —20°C) antibodies to
myosin (monoclonal mouse IgG; Immunotech, Marseille,
France) did not stain, thus excluding mesangial cells. Antibod-
ies to vimentin (monoclonal mouse IgG dilution 1:20; Dako-
patts, Glostrup, Denmark) stained intracellular filament (Fig.
1B). For staining of surface protein, the cells were fixed with
methanol (100% for S mm at —20°C). The cells were negative for
factor VIII (monoclonal mouse IgG; Immunotech), thus exclud-
ing endothelial cells and for leukocyte markers (monoclonal
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mouse IgG; Becton-Dickinson, and Ortho, Neckargemund,
FRG) but were positive for insulin-receptor (monoclonal mouse
IgG dilution 1:10; Immunotech) (Fig. lC). As a second anti-
body, an FITC-conjugated AB was used (sheep anti-mouse
dilution 1:40; Boehringer, Mannheim, FRG).
Complement components
As source of complement, highly purified C5b6, C7, C8 and
C9, isolated from human serum were used. C5b6 was prepared
as described by Yamamoto and Gewurz [22]. C7 and C9 were
prepared as described by Hammer et al [23] and C8 as by
Steckel et a! [24]. The components were hemolytically active as
tested in a modified reactive lysis system [251. Human serum
(NHS) was obtained from healthy donors and tested for hemo-
lytic activity with sensitized sheep erythrocytes as described in
[26]. A serum deficient in C8 (R-C8) was obtained from a patient
with a hereditary C8/3-chain deficiency [27]; purified C8 re-
stored the hemolytic activity: when R-C8 (diluted 1:20) was
mixed with sensitized sheep erythrocytes and C8, the lysis was
dependent on the C8-concentration.
Stimulation of the GEC by the late complement components
C5b-9
For stimulation, the cells were seeded in 24-well plates. At
near confluence, the cells were washed in serum-free medium.
To each well, 100 d of serum-free medium was given. The
terminal complement components were added consecutively.
Of C5b6, 1 to 4 tg were used, of C7 I g, C8 2 g and C9 1 sg.
As controls, single complement components or inactivated
CSb-9, generated by incubating the single components for one
hour at 37°C prior to addition to the cells were used. To
measure spontaneous production, culture medium without
complement was added ("medium control"). After 20 minutes,
during which the C5b-9assembles on the cells, the supernatants
were removed, the cells were washed once and serum-free
medium (1 ml) containing 3H-proline was added.
For activation with whole serum (NHS), zymosan (Sigma
Co., MUnchen, FRG) was washed repeatedly in hot 0.9% NaCl,
then suspended in RPM! to a final concentration of 4 mg/mI. To
each well 10 l of the zymosan suspension was added together
with 100 1.d NHS or R-C8, respectively, and 900 l serum-free
culture medium. After 20 minutes the supernatants were re-
moved and the cells were washed in medium. 3H-proline in
culture medium was added. After 24 hours, incorporation of
radioactivity was measured. All stimulation experiments were
carried out in six parallel wells containing cells at near conflu-
ence as judged microscopically. The supernatants of the six
were pooled and analyzed. The remaining cells were scraped off
and the proteins solubilized by 2% SDS. The protein content
was measured by the Lowry method. The amount of protein
ranged from 120 to 150 g/we11. By pooling cells of six wells, the
differences in protein content became negligible.
Collagen synthesis
De novo collagen synthesis was measured by incorporating
3H-proline into the collagenase-digestible material by a method
modified after Peterkofsky and Diegelmann [28] and Killen and
Striker [29]. GEC were incubated for two hours in serum-free
Minimal Essential Medium with Hanks' salt (MEM) (Serva Co,
Heidelberg, FRG), each containing 0.1 M of L-alanine, L-
asparagine, L-aspartic acid, L-glutamine, L-glutamic acid, gly-
cine, L-serine (all amino acids obtained from Serva), 1%
vitamin mix and 1% antibiotics in the presence of /3-amino-
proprionitrile and Na-ascorbate, 50 sg/ml each (Sigma). Then
the C5b-9 or the controls mentioned above were added and
allowed to bind to the cell for 10 minutes. The cells were then
washed again and cultivated further with the medium containing
3H-proline (specific activity 900 mCi/mg, concentration 1.0
mCi/ml, Amersham Buchler, Braunschweig, FRG) in a concen-
tration of 20 ttCi/ml/well. After 24 hours of incubation at 37°C,
supernatants of six wells were pooled. To the supernatant,
EDTA was added to a final concentration of 10 m. The
supernatants were concentrated and dialyzed using an Centri-
con 30 microconcentrator (Amicon, Witten, FRG). After five
dialysis-concentration steps (the last dialysis without EDTA)
free 3H-proline was no longer detectable in the concentrates;
the filtrate showed only minimal amounts of radioactivity.
Co/la genase digestion
Collagenase (CLSPA Worthington, purchased from Cooper
Biomedicals, MUnchen, FRG) 100 units, in a total volume of 1
ml 0.05 M Hepes buffer without EDTA, containing 20 mri
PMSF 1 m (Sigma) was added to the concentrated
supernatants (500 sl) to inhibit serine protease activities. After
incubation for 60 hours at 37°C, the samples were again
concentrated and dialyzed in Centricon devices. Aliquots of the
filtrates and the concentrates were counted in the /3-counter or
applied to SDS-PAGE, respectively. In parallel to the collage-
nase-digest, supernatants were incubated in the HEPES buffer
containing PMSF. With different cells, different incorporation
of 3H-proline was seen (compare Table 2); however, in all
experiments 65 to 80% of the material was collagenase digest-
ible.
SDS-PAGE, Western-blotting and autoradiography
Polyacrylamide gradient gels (4 to 17%) in a Lämmli system
were used [30]. Of the concentrates, 50 d were applied after
boiling with sample buffer, containing 5% 2-mercaptoethanol
(Biorad, München, FRG). As molecular weight markers, gelatin
monomers (95 kD), dimers (190 kD) and trimers (285 kD)
(Serva) were used. After the run, the proteins were transferred
to nitrocellulose (Schleicher und SchUll, Dassel, FRG), stained
with Ponceau Red (Sigma Diagnostics) diluted 1:2 in water.
From each lane strips were cut, covered with Tris-buffered
saline pH 7.4 (TBS), containing 2% casein. A monoclonal
antibody against human type IV collagen (PHM 12, Australian
Monoclonal Development, provided by Sebak, Aidenbach,
FRG) was used in a final concentration of 1:100. The antibody
does not react with other collagens [31] or with fibronectin. To
test for cross reactivity, such as, with fibronectin, reactivity of
the antibody with components of normal human serum, sepa-
rated by SDS-PAGE under reducing conditions was assayed
after blotting. With the concentrations used (dilution 1:100 to
1:1 000) no reactivity with fibronectin or any other serum
protein was seen. As second antibody, peroxidase-conjugated
anti-mouse IgG (Dianova, Hamburg, FRG) was used in final
concentration of 1:5000.
For autoradiography the gels were soaked for 45 minutes in
Enlightening rapid autoradiography enhancer (NEN, Dreieich,
180 kDaØ .ii
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Table 1. Collagen synthesis in GEC after stimulation with C5b-9 for
24 hours
Basal collagen Human GEC Rat GEC
Production I ,604a 1,426
After stimulation with
C5b9b 34,701 22,290
C5b-8 28,304 16,420
[C5b-9} 1 hr, 370CC 3,781 ND
C5b6, C8, C9 4,322 4,001
C7 976 3,960
a Measured as incorporation of 3H-proline (cpm) into the collagenase-
digestible protein of supernatants pooled from six parallel cultures
obtained from one donor
b C5b6 2 g, C7 1 g, C8 2 g, C9 I g
C All components incubated together for 1 hour at 37°C prior to
addition to the cells
Results
Fig. 2. Collagen synthesis in human GEC. After incubation with
3H-proline (24 hr) supernatants of GEC were dialyzed, separated by
SDS-PAGE and autoradiographed (1). Lane 2 shows the same sample
after digestion with collagenase (cd). In an immunoblot (3), the 180 kD
band reacted with an antibody to type IV collagen.
FRG) and dried afterwards. The films (Kodak, XAR5) were
exposed to the gels for 5 to 10 days.
Quantitation of collagen synthesis
Various methods were used for quantitation. To measure
over-all synthesis, radioactivity associated with the collagenase
digestable material was counted. To compare the relative
increase in collagen synthesis, the autoradiographs were
scanned in a Hitachi Scanner and the areas under the peaks
were quantitated. By this method, the incorporation of 3H-
proline into individual bands could be determined. Further-
more, after autoradiography, the 180 kD band was sliced from
the dried gel and after solubilization in H202 (30%, 80°C, 30
mm) and suspension in Unisolve (Zinsser, Frankfurt, FRG)
counted in a 13-counter.
Antibody to interleukin I (IL-i). The antibody was obtained
from Genzyme purchased through ICN Chemicals, MUnchen.
In a 1:10 ratio (vol/vol) the antibody inhibited the IL-i induced
collagen-synthesis [32]. To test its effect on the C5b-9-induced
collagen synthesis, 5, 10 or 20 .d anti-IL-i was added per well
(1 ml volume) together with the C5b-9.
Glomerular epithelial cells (GEC) in culture spontaneously
produce matrix, among others, collagen type IV (Fig. 1D). To
quantitate the synthesis GEC were cultivated in the presence of
radiolabeled proline under conditions preventing cross linking
of collagen. After 24 hours, cell supernatants of six wells were
taken, and after dialysis analyzed by SDS-PAGE and autoradi-
ography. In the autoradiograph a major band was seen in the
area of 180 kD, and a weaker band at 170 kD. By collagenase-
treatment, the radioactive-labeled protein could be digested.
After blotting, the 180 kD band reacted with a monoclonal
antibody directed against type IV collagen (Fig. 2).
To determine the effect of the terminal complement proteins
on collagen synthesis, highly purified proteins were added to
the cultures. C5b6, C7, C8 and C9 were added sequentially to
allow complex formation on the cell membrane; after 10 min-
utes the supernatants were removed, and cells were washed to
remove the unattached fluid phase C5b-9.
After 24 hours the incorporation of radioactivity into the
protein fraction was measured and compared to GEC that had
been incubated in parallel, but in the absence of complement
(data for one donor are shown in Table I). Separation of the
proteins by SDS-PAGE showed that the radioactivity was
mainly associated with the 180 kD band (Fig. 3).
To test for collagenase-mediated cleavage, the concentrated
and dialyzed supernatants were split in two aliquots. One was
incubated with collagenase, the other only in the HEPES buffer
containing PMSF. After sixty hours, the supernatants were
transferred to Centricon devices and the filtrates and concen-
trates counted (Table 2). The effect of C5b-9 was dose depen-
dent; when C5b6 was added in various amounts, and C7-9 in
excess (determined by hemolysis assays) the incorporation of
3H-proline in the 180 kD/l70 kD peak increased with the C5b6
concentration, the latter determining the degree of C5b-9 com-
plex formation. In the areas of 65 and 43 kD additional bands
appeared with high C5b-9 concentrations (Fig. 3). The 180 kD
and the 65 kD band reacted with an antibody to collagen type IV
as detected by immunoblotting (Fig. 3). C5b-9 complex forma-
tion on the membrane appears to be required. When C5b6, C7,
C8 and C9 were incubated prior to the addition to the GEC (1
hr, 37°C), collagen synthesis was not stimulated, being in
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Fig. 3. Stimulation of collagen synthesis by C5b-9. GEC were stimu-
lated with increasing doses of C5b6 and excess C7, C8 and C9, and the
supematants were separated by SDS-PAGE. The autoradiograph
shows that with increasing doses of C5b-9 an increased intensity of the
180 kD is found. With large doses (first lane) in addition to the 180 kD
band, other bands appeared also.
Table 2. Stimulation of collagen synthesis after exposur
obtained from different donors by C5b-9
e of GEC
GEC
prepara-
tion
After exposure to
[C5b-9]
Basal 1 hr
production C5b-9 37°C C5b6,78 C7
Donor 7
8
16
18
23
24
29
30
924 4,771 ND 1,008
4,304 45,680 ND 6,028
1,604 34,701 3,781 4,322
1,304 38,602 2,604 ND
1,285 24,001 ND 2,480
4,760 21,382 ND ND
989 6,934 ND 1,109
820 10,458 794 ND
ND
ND
976
ND
2,104
ND
824
ND
accordance with the fact that fluid-phase-formed C5b-9 com-
plexes loose their membrane binding capacity (Table 1).
The stimulation experiments were repeated with GEC ob-
tained from eight different kidney donors. Comparing the spon-
taneous collagen production as well as the collagen production
after C5b-9 treatment, there were considerable differences
between the kidney donors. In all assays, however, an increase
in collagen synthesis was seen, reaching from 7- to 40-fold
enhancement (Table 2, Fig. 4).
Fig. 4. Stimulation of collagen type IV synthesis by C5b-9. To GEC,
C5b6 5 sg, C7 I jsg, C8 2 sg and C9 1 sg were added in the presence
of 3H-proline. After 24 hr, the supernatant was subjected to SDS-PAGE
and autoradiography. The autoradiography was scanned. Peaks at 180,
65 and 43 kD were seen. The numbers indicate the relative areas under
the peaks. The protein of the 180 kD peak reacted with an antibody to
collagen type IV.
To exclude contaminations present in the complement pro-
tein preparations (such as, lipopolysaccharides) the effects of
single complement proteins were tested. None of the single
proteins affected the collagen synthesis; with one factor missing
also, such as, C7, C5b6, C8 and C9 were not able to increase
collagen synthesis (Table 1). However, in the absence of C9,
C5b-8 did stimulate the collagen synthesis (Table 1). With rat
glomerular cells, essentially similar data were obtained: C5b-9
as well as C5b-8 increased the collagen synthesis, whereas the
single components or a mixture with one of them missing failed
to do so (Table 1). Due to the limited amount of cells that could
be cultivated from one donor, it was not possible to perform all
the controls, preformed C5b-9, the single components as well as
C5b6, 89 in each experiment. However, in all experiments one
control experiment, performed C5b-9 or C5b6, 89 or C7 were
run in parallel. As expected, neither preformed C5b-9 nor the
single components were able to stimulate the cells, being in line
with their lack of lytic activity and their failure to stimulate
other cells [12—19].
To determine the time course of collagen synthesis, incorpo-
ration of 3H-proline into the 180 kD band was measured
different times after exposure to a limited dose of C5b-9.
Already after six hours, an increase in 3H-incorporation was
seen (Fig. 5).
To test whether or not the C5b-9 doses employed were indeed
non-lethal, the viability of the cells was determined by trypan-
blue exclusion or by measuring release of lactate-dehydroge-
64.4
14.7 15.2
180 65 43
top
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Fig. 5. Time course of collagen type IV synthesis. The incorporation of
radioactivity into the collagenase-digestible protein was measured
various times following exposure of GEC to C5b6 2 g, C7 I pg. C8 2
pg and C9 I pg.
nase. With the C5b-9 doses employed, no killing was seen, and
the cell culture could be continued.
Since we had shown recently that interleukin 1 enhances the
collagen synthesis in GEC [32] and since C5b-9 stimulates the
interleukin 1 (IL-i) synthesis in monocytes and glomerular
mesangial cells [16, 17], we tested in our GEC cultures whether
the increase in collagen synthesis was a direct effect of C5b-9 or
was brought about indirectly via a production of IL-I. Antibod-
ies to IL-i, known to inhibit the IL-l mediated collagen
synthesis [32], did not affect the C5b-9-mediated increase in
collagen synthesis (Table 3). Moreover, GEC neither from rats
nor from the human, released IL-i into the supernatant as
measured by the thymocyte proliferation assay or by radioim-
munoassay (data not shown).
Next, it was tested whether complement activation in whole
serum would also result in a cell-activating C5b-9 complex.
Zymosan particles known to activate complement by the alter-
native pathway were added together with human serum to
human GEC in culture. After 20 minutes, the supernatants were
removed. Complement activation, including the terminal com-
ponents, was measured by titrating the consumption of whole
complement and of C8 in hemolytic assays. Complement con-
sumption to about 90% was seen; the C8 hemolytic titer was
reduced by 80%, indicating complement activation up to termi-
nal complex. After 24 hours, incorporation of 3H-proline into
the 180 kD band was measured. Activated serum in a final
concentration of 10% stimulated the collagen synthesis. Zymo-
san alone was not stimulatory. When a serum deficient in C8
(R-C8) was used, collagen synthesis was reduced. Addition of
C8 restored the activity, indicating that the terminal compo-
nents, when activated in whole serum, exert a stimulatory
function (Table 4).
Basal productiona
Anti-IL-I
After exposure to
C5b-9
Anti-IL-i
Donor 16
Donor 31
Donor 29
1,604
3,401
989
ND
2,890
1,004
34,701
27,912
6,934
12,940
28,412
6,270
a See Table I
Basal collagen production I ,423a
Zymosan-activated NHS 64,790
Zymosan-activated R-C8D 21,304
Zymosan-activated R-C8D + C8 48,721
Non-activated NHS
Non-activated R-C8D zymosan
9,770
1,987
Discussion
In the present study we investigated modulation of the
collagen synthesis of GEC by the terminal complement compo-
nents. Collagen synthesis was quantitated by biosynthetic la-
beling with 3H-proline. After addition of C5b-9 or C5b-8 radio-
activity associated with bands of apparent molecular weights of
180 kD/l70 kD was seen. With large C5b-9 concentration also
double or triple bands between 160 and 170 kD appeared, as
well as a 65 kD and a 43 kD protein band. The estimation of the
size by SDS-PAGE was achieved by the use of gelatin poly-
mers, as they bear a closer structural similarity to collagens
than to globular proteins, which are usually used as marker
proteins. Considerable differences in the apparent molecular
weight were seen when globular protein marker were used: the
180 kD band appeared then as a 220 to 240 kD protein. When
tested by immunobloting, reactivity with antibodies to type IV
collagen could be demonstrated for the 180 kD band, indicating
that indeed the type IV collagen synthesis was enhanced.
Whether or not the other labeled proteins represented other
collagen types or collagen type IV split products devoid of the
respective antigen epitopes has to be tested as yet. So far, only
type IV production has been described for GEC [29]. However,
it is feasible that by vigorous stimulation the pattern of collagen
types might change.
To approach the in vivo situation more closely, stimulation of
the cells in a serum environment was tested. Even though
normal human serum contains abundant amounts of inhibitors
of complement activation and complement functions, a C8
dependent stimulation was seen in zymosan-activated serum.
Since C5b-9 formation is the only known function of C8, our
data indicate that in serum C5b-9 also efficiently increases the
collagen synthesis. The signal for collagen synthesis appears to
be the assembly of C5b-9 or C5b-8 on the membrane. In sublytic
doses, C5b-9 and C5b-8 stimulate a number of cells to release
mediators [12—19] to cause membrane depolarization and to
cause an increase in intracellular Ca and cAMP [33—35].
C5b-8 was equally efficient, being in line with earlier observa-
tions with other cells [13, 14].
Table 3. Collagen synthesis in the presence of anti-IL-i of human
GEC after stimulation with C5b-9
x lO3cpm
24
20
Ca
2 16
>-
Ca
a)C)
C-)
12
8
4
Table 4. Collagen synthesis in human GEC stimulated with activated
serum for 24 hours
I I
1 6 12
Time in culture, hours
a Measured as incorporation of 3H-proline (cpm) into the collagenase-
_.i.__ digestible material of supernatants of six parallel cultures obtained from
24 one donor.
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On the biological or pathophysiological relevance of the
C5b-9-modulated collagen production can only be speculated.
Enhancement of collagen synthesis might on one hand lead to a
thickening or doubling of the glomerular basement membrane, a
condition seen in some forms of glomerulonephritis; it could
also lead to sclerosis, which in some instances, involves depos-
its of collagen type IV [36]. Alternatively, it could have a
beneficial function as a repair mechanism to counterbalance
destruction of the GBM by endogenous collagenases.
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